- E28.39 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM E28.39 became effective on October 1, 2022.
- This is the American ICD-10-CM version of E28.39 – other international versions of ICD-10 E28.39 may differ.
ICD-10-CM E28.39 is grouped within Diagnostic Related Group(s):
- 742 Uterine and adnexa procedures for non-malignancy with cc/mcc
- 743 Uterine and adnexa procedures for non-malignancy without cc/mcc
- 760 Menstrual and other female reproductive system disorders with cc/mcc
- 761 Menstrual and other female reproductive system disorders without cc/mcc
Applicable To
- Decreased estrogen
- Resistant ovary syndrome
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to E28.39:
- estrogen > Decrease (d)
- ovarian > Deficiency, deficient
- secretion > Deficiency, deficient
- ovary > secretion E28.39
- ovarian (primary) > Failure, failed
- ovary > Hypofunction
- female > Hypogonadism
- ovarian (primary) > Hypogonadism
- ovary > Hyposecretion
- ovarian failure > due to N88.3
- gonadal > Insufficiency, insufficient
- ovary > gonadal E28.39
- resistant syndrome > Ovary, ovarian
- ovarian secretion > Suppression
- resistant > ovary E28.2
- resistant ovary > Syndrome